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Introduction
Congenital hyperinsulinism (CH) is a major cause of
recurrent hypoglycaemia in neonates and infants, results
in varying degrees of neurological impairment. Advances
in molecular study and imaging technique have been
used to guide treatment option for CH. However, there
were centres treating CH with long-term medications
and reported good neurodevelopmental outcome.
Objective
To describe short-term outcome of infants with CH in
Putrajaya Hospital, Malaysia.
Method
Medical data of all patients diagnosed with CH between
15 October 2007 and 31 December 2011 was retrieved
from electronic medical record. Their clinical features
and treatment outcome were reviewed. Genetic study
was performed in Exeter, United Kingdom.
Results
Five infants were reported. Hypoglycaemic seizure was
the commonest presenting feature. All had detectable
insulin level (>5 mU/l) during hypoglycaemic episodes
and high glucose requirement (>10 mg/kg/min). Three
patients were found to have genetic mutation associated
with CH. Patient 1 had hyperammonaemia hyperinsulin-
ism syndrome and corresponded missense mutation of
GLUD1 gene. For past 2.5 years, there was good
response to diazoxide treatment. Patient 2 had diffuse
disease with homozygous mutation at the ABCC8 gene.
She presented at birth with severe disease and required
combination of medications including octreotide. It was
complicated by epilepsy, and developmental milestones
were mildly delayed. Patient 3 inherited a heterozygous
mutation in the KCNJ11 gene from the father (presumed
focal disease). He responded only to octreotide and
showed normal development at nine months old.
Another two patients had no common mutation
detected. Patient 4 required combination of therapy initi-
ally, but subsequently treated with diazoxide alone and
weaned off nasogastric feeding at five years old. Patient 5
had features suggestive of Beckwith-Wiedemann
syndrome and did not respond to all medical therapy.
Pancreatectomy was performed at 3 months old and he
died from complications of surgery.
Conclusion
Molecular genetic study is useful in the management of
neonates and infants with CH. Patients with focal and
diffuse disease were shown to respond to medical
therapy.
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